Pharmaceutical Technology2h
EC approves GSK’s Jemperli-chemo combo for endometrial cancer
The EC has approved GSK's Jemperli (dostarlimab) combined with chemotherapy for primary advanced or recurrent endometrial cancer in adults.
Pharmaceutical Technology18h
KeyMed partners with US-based biotech Prolium in bispecific antibody deal
Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...
Pharmaceutical Technology18h
FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals
This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on ...
Pharmaceutical Technology17h
$590m to Moderna from HHS for mRNA ‘flu vax development
Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...
Pharmaceutical Technology23h
Feinstein Institutes gains NIH grant to explore ghrelin for GI-ARS
Northwell Health’s Feinstein Institutes for Medical Research has received a $2.9m grant from the NIH to explore the use of ...
Pharmaceutical Technology22h
AstraZeneca secures first BTK approval in first-line mantle cell lymphoma
AstraZeneca has received approval from the FDA for its BTK inhibitor, Calquence (acalabrutinib), for first-line use in MCL.
Pharmaceutical Technology20h
Interleukin inhibitors remain a strong growth driver in dermatology
If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.